CGC
Price
$0.92
Change
-$0.03 (-3.16%)
Updated
Apr 4 closing price
Capitalization
784.64M
55 days until earnings call
INCR
Price
$1.28
Change
-$0.06 (-4.48%)
Updated
Apr 4, 04:57 PM (EDT)
Capitalization
123.5M
2 days until earnings call
Ad is loading...

CGC vs INCR

Header iconCGC vs INCR Comparison
Open Charts CGC vs INCRBanner chart's image
Canopy Growth
Price$0.92
Change-$0.03 (-3.16%)
Volume$4.21M
Capitalization784.64M
Intercure
Price$1.28
Change-$0.06 (-4.48%)
Volume$100
Capitalization123.5M
CGC vs INCR Comparison Chart
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. INCR commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and INCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (CGC: $0.95 vs. INCR: $1.34)
Brand notoriety: CGC: Notable vs. INCR: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 59% vs. INCR: 80%
Market capitalization -- CGC: $784.64M vs. INCR: $123.5M
CGC [@Pharmaceuticals: Other] is valued at $784.64M. INCR’s [@Pharmaceuticals: Other] market capitalization is $123.5M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileINCR’s FA Score has 1 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • INCR’s FA Score: 1 green, 4 red.
According to our system of comparison, INCR is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 5 TA indicator(s) are bullish while INCR’s TA Score has 4 bullish TA indicator(s).

  • CGC’s TA Score: 5 bullish, 3 bearish.
  • INCR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CGC is a better buy in the short-term than INCR.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а -9.78% price change this week, while INCR (@Pharmaceuticals: Other) price change was -5.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.71%. For the same industry, the average monthly price growth was -3.64%, and the average quarterly price growth was -11.61%.

Reported Earning Dates

CGC is expected to report earnings on May 30, 2025.

INCR is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.71% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($785M) has a higher market cap than INCR($124M). INCR YTD gains are higher at: -15.717 vs. CGC (-65.427). INCR has higher annual earnings (EBITDA): 25.8M vs. CGC (-1.02B). CGC has more cash in the bank: 186M vs. INCR (103M). INCR has less debt than CGC: INCR (163M) vs CGC (693M). INCR has higher revenues than CGC: INCR (415M) vs CGC (362M).
CGCINCRCGC / INCR
Capitalization785M124M633%
EBITDA-1.02B25.8M-3,963%
Gain YTD-65.427-15.717416%
P/E RatioN/A22.52-
Revenue362M415M87%
Total Cash186M103M181%
Total Debt693M163M425%
FUNDAMENTALS RATINGS
CGC vs INCR: Fundamental Ratings
CGC
INCR
OUTLOOK RATING
1..100
6866
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
9685
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INCR's Valuation (57) in the Servicestothe Health Industry industry is somewhat better than the same rating for CGC (93) in the Agricultural Commodities Or Milling industry. This means that INCR’s stock grew somewhat faster than CGC’s over the last 12 months.

INCR's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that INCR’s stock grew similarly to CGC’s over the last 12 months.

INCR's SMR Rating (94) in the Servicestothe Health Industry industry is in the same range as CGC (98) in the Agricultural Commodities Or Milling industry. This means that INCR’s stock grew similarly to CGC’s over the last 12 months.

INCR's Price Growth Rating (85) in the Servicestothe Health Industry industry is in the same range as CGC (96) in the Agricultural Commodities Or Milling industry. This means that INCR’s stock grew similarly to CGC’s over the last 12 months.

INCR's P/E Growth Rating (3) in the Servicestothe Health Industry industry is significantly better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that INCR’s stock grew significantly faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCINCR
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 22 days ago
72%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POVSX27.12N/A
N/A
Putnam International Equity A
PGEOX24.98N/A
N/A
George Putnam Balanced A
AAIIX7.11N/A
N/A
Ancora Income I
WISGX19.77N/A
N/A
Segall Bryant & Hamill Small Cap GrInstl
OGFAX85.10N/A
N/A
JPMorgan Equity Index R6

INCR and

Correlation & Price change

A.I.dvisor tells us that INCR and TLRY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
-2.54%
TLRY - INCR
29%
Poorly correlated
-5.14%
CGC - INCR
28%
Poorly correlated
-9.78%
KMDA - INCR
28%
Poorly correlated
-6.41%
ACB - INCR
27%
Poorly correlated
-4.03%
SNDL - INCR
25%
Poorly correlated
-1.39%
More